Blog

BIO

Prof de Magalhaes graduated in Microbiology in 1999 from the
Escola Superior de Biotecnologia in his hometown of Porto,
Portugal, and in 2004 obtained a PhD in Biological Sciences from
the University of Namur in Belgium. Following further training in
genetics at Harvard Medical School (Boston, USA), in 2008 Prof de
Magalhaes joined the University of Liverpool in the UK and
established the Integrative Genomics of Ageing group. His research
on genetics, ageing and longevity has been widely featured in scientific magazines (Science, Nature, Scientific American, New Scientist, etc.), and he has published over 100 scientific papers.

Prof de Magalhaes is a world leader in big data and computational analyses, including genomics and machine learning, in ageing, longevity and age-related diseases. In addition, he has a long-term interest in technological trends and their future impact on society. His work on predicting how technology will shape the human condition has been published in magazines such as Futures and The Futurist, and in newspapers like The Independent.

Prof de Magalhaes has given over 100 invited talks in international conferences, including three TEDx talks, and in many academic institutions and companies (e.g., Google’s Calico and Allianz). He also makes regular media appearances (BBC, CNN, the Washington Post,
the Financial Times and many others). Prof de Magalhaes is an advisor/consultant for various organizations, including non-profit foundations and charities, universities, investment funds and biotech companies. He is Chief Scientific Officer of Centaura, an ambitious
biotech company in Switzerland focused on healthy ageing and founded his own his company Magellan Science Ltd.